Ibritumomab Tiuxetan and NovoSeven RT
Determining the interaction of Ibritumomab Tiuxetan and NovoSeven RT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-NovoSeven RT with MixPro injection
- Ibritumomab Tiuxetan-Novothyrox
- Ibritumomab Tiuxetan-Noxafil
- Ibritumomab Tiuxetan-Noxafil (Posaconazole Delayed-Release Tablets)
- Ibritumomab Tiuxetan-Noxafil (Posaconazole Injection)
- Ibritumomab Tiuxetan-Noxafil (Posaconazole Oral Suspension)
- NovoSeven RT-Ibrutinib
- NovoSeven RT-Ibrutinib Capsules
- NovoSeven RT-Ibrutinib Tablets
- NovoSeven RT-Ibu
- NovoSeven RT-IBU Tablets
- NovoSeven RT-Ibu-2